tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

MNPR Stock Latest News

Monopar Therapeutics price target raised to $40 from $22 at H.C. Wainwright
The FlyMonopar Therapeutics price target raised to $40 from $22 at H.C. Wainwright
1M ago
MNPR
Monopar Therapeutics files to sell 882,761 shares of common stock for holders
PremiumThe Fly
Monopar Therapeutics files to sell 882,761 shares of common stock for holders
1M ago
MNPR
Monopar Therapeutics initiated with an Overweight at Piper Sandler
PremiumThe Fly
Monopar Therapeutics initiated with an Overweight at Piper Sandler
1M ago
MNPR
These 2 Monster Growth Stocks Skyrocketed Over 1,000% This Year — Here’s What Analysts Expect in 2025
PremiumStock Analysis & Ideas
These 2 Monster Growth Stocks Skyrocketed Over 1,000% This Year — Here’s What Analysts Expect in 2025
2M ago
DAVE
MNPR
Monopar Therapeutics prices 798,655 shares at $23.79 in registered offering
PremiumThe Fly
Monopar Therapeutics prices 798,655 shares at $23.79 in registered offering
2M ago
MNPR
Monopar Therapeutics Achieves Milestone in Cancer Treatment
PremiumCompany AnnouncementsMonopar Therapeutics Achieves Milestone in Cancer Treatment
3M ago
8K
MNPR
Monopar Therapeutics doses first patient with MNPR-101-Lu
Premium
The Fly
Monopar Therapeutics doses first patient with MNPR-101-Lu
3M ago
MNPR
Monopar Therapeutics price target raised to $37 from $9 at JonesResearch
Premium
The Fly
Monopar Therapeutics price target raised to $37 from $9 at JonesResearch
3M ago
MNPR
Monopar Therapeutics price target raised to $22 from $6 at H.C. Wainwright
PremiumThe Fly
Monopar Therapeutics price target raised to $22 from $6 at H.C. Wainwright
3M ago
MNPR
Monopar Therapeutics reports Q3 EPS (37c), consensus (48c)
PremiumThe Fly
Monopar Therapeutics reports Q3 EPS (37c), consensus (48c)
4M ago
MNPR
Monopar Therapeutics Closes $19.2 Million Stock Offering
PremiumCompany Announcements
Monopar Therapeutics Closes $19.2 Million Stock Offering
4M ago
8K
MNPR
Monopar Therapeutics 1.16M share Spot Secondary priced at $16.25
PremiumThe Fly
Monopar Therapeutics 1.16M share Spot Secondary priced at $16.25
4M ago
MNPR
Monopar Therapeutics announces common stock offering, no amount given
PremiumThe FlyMonopar Therapeutics announces common stock offering, no amount given
4M ago
MNPR
Monopar Therapeutics Secures License for Wilson Disease Treatment
Premium
Company Announcements
Monopar Therapeutics Secures License for Wilson Disease Treatment
4M ago
8K
MNPR
Monopar Therapeutics enters agreement with Alexion, AstraZeneca Rare Disease
Premium
The Fly
Monopar Therapeutics enters agreement with Alexion, AstraZeneca Rare Disease
4M ago
MNPR
Monopar Therapeutics Unveils Promising Radiopharmaceutical Data
PremiumCompany Announcements
Monopar Therapeutics Unveils Promising Radiopharmaceutical Data
4M ago
8K
MNPR
Monopar Therapeutics presents data from radiopharma program based on MNPR-101
PremiumThe Fly
Monopar Therapeutics presents data from radiopharma program based on MNPR-101
4M ago
MNPR
Monopar Therapeutics Expands Portfolio with New Patent Filing
PremiumCompany Announcements
Monopar Therapeutics Expands Portfolio with New Patent Filing
4M ago
8K
MNPR
Monopar files provisional patent covering therapeutic radiopharmaceuticals
PremiumThe Fly
Monopar files provisional patent covering therapeutic radiopharmaceuticals
4M ago
MNPR
Monopar Therapeutics initiated with a Buy at Rodman & Renshaw
PremiumThe FlyMonopar Therapeutics initiated with a Buy at Rodman & Renshaw
4M ago
MNPR
Monopar Therapeutics initiates Phase 1a trial for MNPR-101-Lu
Premium
The Fly
Monopar Therapeutics initiates Phase 1a trial for MNPR-101-Lu
5M ago
MNPR
Monopar Therapeutics Launches Phase 1a uPAR-Targeted Cancer Trial
Premium
Company Announcements
Monopar Therapeutics Launches Phase 1a uPAR-Targeted Cancer Trial
5M ago
8K
MNPR

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >